Copyright Reports & Markets. All rights reserved.

Global Cardiac Resynchronization Therapy (CRT) Devices Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Cardiac Resynchronization Therapy (CRT) Devices Market Overview

      • 1.1 Product Overview and Scope of Cardiac Resynchronization Therapy (CRT) Devices
      • 1.2 Cardiac Resynchronization Therapy (CRT) Devices Segment by Type
        • 1.2.1 Global Cardiac Resynchronization Therapy (CRT) Devices Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 CRT-Pacemakers
        • 1.2.3 CRT-Defibrillators
      • 1.3 Cardiac Resynchronization Therapy (CRT) Devices Segment by Application
        • 1.3.1 Cardiac Resynchronization Therapy (CRT) Devices Consumption Comparison by Application (2014-2025)
        • 1.3.2 Healthcare Industry
        • 1.3.3 Cardiovascular industry
      • 1.4 Global Cardiac Resynchronization Therapy (CRT) Devices Market by Region
        • 1.4.1 Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Cardiac Resynchronization Therapy (CRT) Devices Market Size
        • 1.5.1 Global Cardiac Resynchronization Therapy (CRT) Devices Revenue (2014-2025)
        • 1.5.2 Global Cardiac Resynchronization Therapy (CRT) Devices Production (2014-2025)

      2 Global Cardiac Resynchronization Therapy (CRT) Devices Market Competition by Manufacturers

      • 2.1 Global Cardiac Resynchronization Therapy (CRT) Devices Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Cardiac Resynchronization Therapy (CRT) Devices Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Cardiac Resynchronization Therapy (CRT) Devices Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Cardiac Resynchronization Therapy (CRT) Devices Production Sites, Area Served, Product Types
      • 2.5 Cardiac Resynchronization Therapy (CRT) Devices Market Competitive Situation and Trends
        • 2.5.1 Cardiac Resynchronization Therapy (CRT) Devices Market Concentration Rate
        • 2.5.2 Cardiac Resynchronization Therapy (CRT) Devices Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Cardiac Resynchronization Therapy (CRT) Devices Production Market Share by Regions

      • 3.1 Global Cardiac Resynchronization Therapy (CRT) Devices Production Market Share by Regions
      • 3.2 Global Cardiac Resynchronization Therapy (CRT) Devices Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Cardiac Resynchronization Therapy (CRT) Devices Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Cardiac Resynchronization Therapy (CRT) Devices Production
        • 3.4.1 North America Cardiac Resynchronization Therapy (CRT) Devices Production Growth Rate (2014-2019)
        • 3.4.2 North America Cardiac Resynchronization Therapy (CRT) Devices Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Cardiac Resynchronization Therapy (CRT) Devices Production
        • 3.5.1 Europe Cardiac Resynchronization Therapy (CRT) Devices Production Growth Rate (2014-2019)
        • 3.5.2 Europe Cardiac Resynchronization Therapy (CRT) Devices Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Cardiac Resynchronization Therapy (CRT) Devices Production (2014-2019)
        • 3.6.1 China Cardiac Resynchronization Therapy (CRT) Devices Production Growth Rate (2014-2019)
        • 3.6.2 China Cardiac Resynchronization Therapy (CRT) Devices Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Cardiac Resynchronization Therapy (CRT) Devices Production (2014-2019)
        • 3.7.1 Japan Cardiac Resynchronization Therapy (CRT) Devices Production Growth Rate (2014-2019)
        • 3.7.2 Japan Cardiac Resynchronization Therapy (CRT) Devices Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Cardiac Resynchronization Therapy (CRT) Devices Consumption by Regions

      • 4.1 Global Cardiac Resynchronization Therapy (CRT) Devices Consumption by Regions
      • 4.2 North America Cardiac Resynchronization Therapy (CRT) Devices Consumption (2014-2019)
      • 4.3 Europe Cardiac Resynchronization Therapy (CRT) Devices Consumption (2014-2019)
      • 4.4 China Cardiac Resynchronization Therapy (CRT) Devices Consumption (2014-2019)
      • 4.5 Japan Cardiac Resynchronization Therapy (CRT) Devices Consumption (2014-2019)

      5 Global Cardiac Resynchronization Therapy (CRT) Devices Production, Revenue, Price Trend by Type

      • 5.1 Global Cardiac Resynchronization Therapy (CRT) Devices Production Market Share by Type (2014-2019)
      • 5.2 Global Cardiac Resynchronization Therapy (CRT) Devices Revenue Market Share by Type (2014-2019)
      • 5.3 Global Cardiac Resynchronization Therapy (CRT) Devices Price by Type (2014-2019)
      • 5.4 Global Cardiac Resynchronization Therapy (CRT) Devices Production Growth by Type (2014-2019)

      6 Global Cardiac Resynchronization Therapy (CRT) Devices Market Analysis by Applications

      • 6.1 Global Cardiac Resynchronization Therapy (CRT) Devices Consumption Market Share by Application (2014-2019)
      • 6.2 Global Cardiac Resynchronization Therapy (CRT) Devices Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Cardiac Resynchronization Therapy (CRT) Devices Business

      • 7.1 Boston Scientific
        • 7.1.1 Boston Scientific Cardiac Resynchronization Therapy (CRT) Devices Production Sites and Area Served
        • 7.1.2 Cardiac Resynchronization Therapy (CRT) Devices Product Introduction, Application and Specification
        • 7.1.3 Boston Scientific Cardiac Resynchronization Therapy (CRT) Devices Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Medtronic
        • 7.2.1 Medtronic Cardiac Resynchronization Therapy (CRT) Devices Production Sites and Area Served
        • 7.2.2 Cardiac Resynchronization Therapy (CRT) Devices Product Introduction, Application and Specification
        • 7.2.3 Medtronic Cardiac Resynchronization Therapy (CRT) Devices Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 St. Jude Medical
        • 7.3.1 St. Jude Medical Cardiac Resynchronization Therapy (CRT) Devices Production Sites and Area Served
        • 7.3.2 Cardiac Resynchronization Therapy (CRT) Devices Product Introduction, Application and Specification
        • 7.3.3 St. Jude Medical Cardiac Resynchronization Therapy (CRT) Devices Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Biotronik
        • 7.4.1 Biotronik Cardiac Resynchronization Therapy (CRT) Devices Production Sites and Area Served
        • 7.4.2 Cardiac Resynchronization Therapy (CRT) Devices Product Introduction, Application and Specification
        • 7.4.3 Biotronik Cardiac Resynchronization Therapy (CRT) Devices Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Cook Medical
        • 7.5.1 Cook Medical Cardiac Resynchronization Therapy (CRT) Devices Production Sites and Area Served
        • 7.5.2 Cardiac Resynchronization Therapy (CRT) Devices Product Introduction, Application and Specification
        • 7.5.3 Cook Medical Cardiac Resynchronization Therapy (CRT) Devices Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Sorin Group
        • 7.6.1 Sorin Group Cardiac Resynchronization Therapy (CRT) Devices Production Sites and Area Served
        • 7.6.2 Cardiac Resynchronization Therapy (CRT) Devices Product Introduction, Application and Specification
        • 7.6.3 Sorin Group Cardiac Resynchronization Therapy (CRT) Devices Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served

      8 Cardiac Resynchronization Therapy (CRT) Devices Manufacturing Cost Analysis

      • 8.1 Cardiac Resynchronization Therapy (CRT) Devices Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Cardiac Resynchronization Therapy (CRT) Devices
      • 8.4 Cardiac Resynchronization Therapy (CRT) Devices Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Cardiac Resynchronization Therapy (CRT) Devices Distributors List
      • 9.3 Cardiac Resynchronization Therapy (CRT) Devices Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Cardiac Resynchronization Therapy (CRT) Devices Market Forecast

      • 11.1 Global Cardiac Resynchronization Therapy (CRT) Devices Production, Revenue Forecast
        • 11.1.1 Global Cardiac Resynchronization Therapy (CRT) Devices Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Cardiac Resynchronization Therapy (CRT) Devices Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Cardiac Resynchronization Therapy (CRT) Devices Price and Trend Forecast (2019-2025)
      • 11.2 Global Cardiac Resynchronization Therapy (CRT) Devices Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Cardiac Resynchronization Therapy (CRT) Devices Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Cardiac Resynchronization Therapy (CRT) Devices Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Cardiac Resynchronization Therapy (CRT) Devices Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Cardiac Resynchronization Therapy (CRT) Devices Production, Revenue Forecast (2019-2025)
      • 11.3 Global Cardiac Resynchronization Therapy (CRT) Devices Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Cardiac Resynchronization Therapy (CRT) Devices Consumption Forecast (2019-2025)
        • 11.3.2 Europe Cardiac Resynchronization Therapy (CRT) Devices Consumption Forecast (2019-2025)
        • 11.3.3 China Cardiac Resynchronization Therapy (CRT) Devices Consumption Forecast (2019-2025)
        • 11.3.4 Japan Cardiac Resynchronization Therapy (CRT) Devices Consumption Forecast (2019-2025)
      • 11.4 Global Cardiac Resynchronization Therapy (CRT) Devices Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Cardiac Resynchronization Therapy (CRT) Devices Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        According to the WHO, cardiovascular disease is one of the leading cause of death worldwide. It is estimated that around 17.5 million people died from cardiovascular disease, which accounted for 31% of all global deaths in 2012. Cardiovascular disease can be prevented by addressing behavioral risks such as obesity, cigarette smoking, and an unhealthy diet. CRT device is an implantable medical device that are used to resynchronize the contractions of the heart’s ventricles by sending tiny electrical impulses to the heart muscle, to pump the blood more efficiently.
        One of the various factors that back the market growth of cardiac resynchronization therapy devices market is the expanding pool of aging and geriatric patients worldwide. That segment of the human population is more vulnerable to chronic illness and is, as such, expected to generate the immense need for these resynchronization therapy gadgets so as to facilitate and accelerate sound heart activity. Other than cardiac arrest, there are some other medical conditions like atrial fibrillation, congenital heart disease, and arrhythmias which also require the implementation and usage of these cardiac resynchronization therapy devices.
        Growing prevalence of various cardiovascular diseases like cardiac arrest, sick sinus syndrome, and bradycardia are also bolstering the growth of market. To diminish the rate of mortality arising out of cardiovascular illness, many hospitals have already initiated the use of CRT-Ps for managing the failures of heart. Furthermore, many doctors are increasing the usage of surgeries that are minimally invasive (MI) for various CRT-Ps implantation. These procedures are considered safe, diminish the blood transfusion requirement. It also decreases chances of infections and reduces stay at the hospital. This eventually accelerates the recovering and process thereby leading to much improved clinical outcome. This change in inclination towards minimally invasive procedures for the purpose of CRT-Ps implantation is poised to trigger the sales of the cardiac resynchronization therapy devices in the years to come.
        The North American region is expected to contribute the highest revenue over the forecast period due to rising approvals by the U.S. FDA for new products and increasing growth of geriatric population suffering from cardiac dysfunction. As of 2016, it held more 36.0% of the global market share. Europe also held a substantial share and is predicted to witness lucrative growth with CAGR of more than 7.4% over the next nine years. Higher stringency being implemented by the healthcare agencies toward R&D, safety guideline follow-up, and product approvals are expected to drive the growth.

        The global Cardiac Resynchronization Therapy (CRT) Devices market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Cardiac Resynchronization Therapy (CRT) Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cardiac Resynchronization Therapy (CRT) Devices market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Boston Scientific
        Medtronic
        St. Jude Medical
        Biotronik
        Cook Medical
        Sorin Group
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        CRT-Pacemakers
        CRT-Defibrillators

        Segment by Application
        Healthcare Industry
        Cardiovascular industry

        Buy now